Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma

BJU International

Volumn 110, Issue 11 B, 2012, Pages

  Rao, Sandhya R ^a   Correa, Jose J ^a   Sexton, Wade J ^a   Pow Sang, Julio M ^a   Dickinson, Shohreh I ^a   Lin, Hui Yi ^a   Spiess, Philippe E ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Lymph node dissection; Upper urinary tract; Urothelial carcinoma

Indexed keywords

ADULT; AGED; CANCER PATIENT; CANCER RECURRENCE; CHYLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEASIBILITY STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LENGTH OF STAY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NEPHROURETERECTOMY; PATIENT SAFETY; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; ROBOTICS; SURGICAL APPROACH; TRANSITIONAL CELL CARCINOMA; ARTICLE; COMPARATIVE STUDY; FEMALE; LAPAROSCOPY; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NEPHRECTOMY; PATHOLOGY; PROGNOSIS; RETROPERITONEUM; TREATMENT OUTCOME; URETER; URINARY TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; PROSPECTIVE STUDIES; RETROPERITONEAL SPACE; TREATMENT OUTCOME; URETER; UROLOGIC NEOPLASMS;

MLCS; MLOWN;

EID: 84876449496     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11170.x     Document Type: Review

References (29)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998 ; 48 : 6-29
2. Lerner SE, Blute ML, Richardson RL, Zincke H. Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract. Mayo Clin Proc 1996 ; 71 : 945-50
3. Schatteman P, Chatzopoulos C, Assenmacher C et al. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey. Eur Urol 2007 ; 51 : 1633-8
4. Ozsahin M, Zouhair A, Villa S et al. Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 1999 ; 35 : 738-43
5. Konety BR, Joslyn SA, O ' Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol 2003 ; 169 : 946-50
6. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 2004 ; 172 : 85-9
7. Miyake H, Hara I, Gohji K, Arakawa S, Kamidono S. The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract. Br J Urol 1998 ; 82 : 494-8
8. Komatsu H, Tanabe N, Kubodera S, Maezawa H, Ueno A. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. J Urol 1997 ; 157 : 1622-4
9. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol 2007 ; 178 : 1212-7
10. Roscigno M, Cozzarini C, Bertini R et al. Prognostic value of lymph node dissection in patients with muscleinvasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008 ; 53 : 794-802
11. Brausi MA, Gavioli M, De Luca G et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007 ; 52 : 1414-8
12. Lughezzani G, Jeldres C, Isbarn H et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 2010 ; 75 : 118-24
13. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004 ; 240 : 205-13
14. Epstein JI, Amin MB, Reuter VR, MostofiFK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998 ; 22 : 1435-48
15. Sobin LH, Wittekind C, International Union against Cancer. TNM Classification of Malignant Tumours, 5th edn. New York : J. Wiley, 1997
16. Blom JH, van Poppel H, Marechal JM et al. Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 2009 ; 55 : 28-34
17. Abe T, Shinohara N, Muranaka M et al. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multiinstitutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur J Surg Oncol 2010 ; 36 : 1085-91
18. Roscigno M, Shariat SF, Margulis V et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 2009 ; 181 : 2482-9
19. Evans JG, Spiess PE, Kamat AM et al. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol 2006 ; 176 : 1463-7
20. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 1995 ; 153 : 976-80
21. Williams SB, McDermott DW, Winston D et al. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data. BJU Int 2010 ; 105 : 918-21
22. Luz MA, Kotb AF, Aldousari S et al. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor. World J Surg Oncol 2010 ; 8 : 97-103
23. Rajput MZ, Kamat AM, Clavell- Hernandez J et al. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Urology 2011 ; 78 : 61-7
24. Matin SF. Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status. BJU Int 2005 ; 95 ( Suppl. 2 ): 68-74
25. Rassweiler JJ, Schulze M, Marrero R, Frede T, Palou Redorta J, Bassi P. Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: is it better than open surgery? Eur Urol 2004 ; 46 : 690-7
26. Herr HW, Donat SM. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 2001 ; 165 : 62-4
27. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004 ; 171 : 139-44
28. Secin FP, Koppie TM, Salamanca JI et al. Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. Int J Urol 2007 ; 14 : 26-32
29. Margulis V, Youssef RF, Karakiewicz PI et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 2010 ; 184 : 453-8